Professor Michal Rosen-Zvi, Faculty of Medicine, The Hebrew University

“From Data to Design: AI-Driven Generative Biology and the Future of Personalized Medicine”

Professor Michal Rosen-Zvi is a leading expert in AI for healthcare and life sciences, with research spanning multimodal biomedical foundation models, drug discovery, translational medicine, and scientific AI systems. She has worked at the intersection of computational science and biology, collaborating with leading academic medical centres and pharmaceutical organisations to develop AI-driven approaches that accelerate discovery and improve healthcare. Most recently, she served as Director of AI for Healthcare and Life Sciences at IBM Research, and she is a member of the World Economic Forum’s Global Future Council on Generative Biology. Her keynote will explore how AI is moving biomedical research from analysing data towards designing biological interventions and shaping the future of personalised medicine.

Hear from AstraZeneca across the conference programme to gain the full picture of their multi-omics and data strategy: 

• GÜNTER SCHMIDT, Vice President, Image Data Sciences, Computational Pathology, AI For Science Innovation
• VIRGINIA SAVOVA, Senior Director, Cell-Targeted Precision Medicine, AstraZeneca
• SHIVAPRASAD PATIL, Associate Director, Bioinformatics Imaging & Data Analytics, AstraZeneca 
  

The AI & Data Zone will serve as the central hub for AI-driven biomarker discovery, computational pathology and next generation multi-omics technologies, bringing together innovators across AI platforms, cloud infrastructure, automation, bioinformatics, digital biology, academic hubs, and strategic pharma tech partners. This interactive space will feature poster presentations, live demos, and short tech talks, alongside an AI Networking Lounge and a coffee cart to foster meaningful connections & collaboration  

Join the innovators integrating multi-omics into their R&D pipelines across new and exciting biotechs and mid-size pharma companies including: 

• Amphista Therapeutics
• Gero AI
• Quantro Therapeutics
• Quotient Therapeutics

Explore the role of spatial biomarkers in discovery and development across pharma & academia with representation from: 

• OZLEM AKILLI, Director, Department of Spatial Biology and Cellular Dynamics, TRON
• ALBERTO VALDEOLIVAS URBELZ, Principal Scientist in Computational Biology, Roche
• TATJANA CRNOGORACJURCEVIC, Professor of Molecular Pathology and Biomarkers, Queen Mary University

A panel discussion exploring how AI is reshaping the way we think, and how it may enable us to revisit questions once considered unanswerable. 

• MARTA MILO, Director of Computational Oncology, Data Science & AI, AstraZeneca
• RAGHDA ELDESOUKI, Associate Professor of Medical Genetics, Suez Canal University
• AMIR FEIZII, Head of Translational AI & Target Discovery, Gero AI